{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:04:26Z","timestamp":1760043866052},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/ejhg.2016.69","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T20:18:14Z","timestamp":1466713094000},"page":"1517-1523","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer"],"prefix":"10.1038","volume":"24","author":[{"name":"for the TFGT Collaborative Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Meiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V F","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K M","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K J","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Peate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Geelhoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Barlow-Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Field","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y C","family":"Antill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"BFejhg201669_CR1","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","volume":"33","author":"M Robson","year":"2015","unstructured":"Robson M, Bradbury A, Arun B et al: American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2015; 33: 3660\u20133667.","journal-title":"J Clin Oncol"},{"key":"BFejhg201669_CR2","unstructured":"National Breast and Ovarian Cancer Centre Recommendations for Follow-up of Women with Early Breast Cancer. Surry Hills, NSW, Australia: National Breast and Ovarian Cancer Centre, 2010."},{"key":"BFejhg201669_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","volume":"138","author":"JN Weitzel","year":"2003","unstructured":"Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA : Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 2003; 138: 1323\u20131328.","journal-title":"Arch Surg"},{"key":"BFejhg201669_CR4","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","volume":"24","author":"LJ Pierce","year":"2006","unstructured":"Pierce LJ, Levin AM, Rebbeck TR et al: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer [see comment]. J Clin Oncol 2006; 24: 2437\u20132443.","journal-title":"J Clin Oncol"},{"key":"BFejhg201669_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"P Fong","year":"2009","unstructured":"Fong P, Boss D, Yap T et al: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361: 1\u201312.","journal-title":"N Engl J Med"},{"key":"BFejhg201669_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-014-3100-x","volume":"147","author":"T Byrski","year":"2014","unstructured":"Byrski T, Huzarski T, Dent R et al: Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2014; 147: 401\u2013405.","journal-title":"Breast Cancer Res Treat"},{"key":"BFejhg201669_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1200\/JCO.2014.57.6660","volume":"33","author":"S Isakoff","year":"2015","unstructured":"Isakoff S, Mayer E, He L et al: TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer. J Clin Oncol 2015; 33: 1902\u20131909.","journal-title":"J Clin Oncol"},{"key":"BFejhg201669_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrclinonc.2010.175","volume":"7","author":"A Trainer","year":"2010","unstructured":"Trainer A, Lewis C, Tucker K, Meiser B, Friedlander M, Ward R : Treatment-focused genetic assessment in breast cancer \u2013 the evolving role of the familial cancer services. Nat Rev Clin Oncol 2010; 7: 708\u2013717.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFejhg201669_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jama.2015.8088","volume":"314","author":"S Katz","year":"2015","unstructured":"Katz S, Kurian A, Morrow M : Decision-making and genetic testing for breast cancer. JAMA 2015; 314: 997\u2013998.","journal-title":"JAMA"},{"key":"BFejhg201669_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/bcr2194","volume":"10","author":"B Meiser","year":"2008","unstructured":"Meiser B, Tucker K, Friedlander M et al: Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Canc Res 2008; 10: 216.","journal-title":"Breast Canc Res"},{"key":"BFejhg201669_CR11","first-page":"379","volume":"107","author":"R Manchanda","year":"2015","unstructured":"Manchanda R, Loggenberg K, Sanderson S et al: Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial. J Natl Cancer Inst 2015; 107: 379.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg201669_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"M King","year":"2014","unstructured":"King M, Levy-Lahad E, Lahad A : Population screening for breast cancer. JAMA 2014; 312: 1091\u20131092.","journal-title":"JAMA"},{"key":"BFejhg201669_CR13","doi-asserted-by":"crossref","unstructured":"Hilgart J, Coles B, Iredale R : Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2012; 2: ; CD003721.","DOI":"10.1002\/14651858.CD003721.pub3"},{"key":"BFejhg201669_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1037\/a0014778","volume":"28","author":"JG Hamilton","year":"2009","unstructured":"Hamilton JG, Lobel M, Moyer A : Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 2009; 28: 510\u2013518.","journal-title":"Health Psychol"},{"key":"BFejhg201669_CR15","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.ejca.2006.05.032","volume":"42","author":"KJ Schlich-Bakker","year":"2006","unstructured":"Schlich-Bakker KJ, Warlam-Rodenhuis CC, van Echtelt J, van den Bout J, Ausems MG, ten Kroode HF : Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer. Eur J Cancer 2006; 42: 2722\u20132728.","journal-title":"Eur J Cancer"},{"key":"BFejhg201669_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-007-9680-y","volume":"109","author":"KJ Schlich-Bakker","year":"2008","unstructured":"Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, Warlam-Rodenhuis CC : BRCA1\/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy. Breast Cancer Res Treat 2008; 109: 507\u2013514.","journal-title":"Breast Cancer Res Treat"},{"key":"BFejhg201669_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/gim.2012.31","volume":"14","author":"S Shkedi-Rafid","year":"2012","unstructured":"Shkedi-Rafid S, Gabai-Kapara E, Grinshpun-Cohen J, Levy-Lahad E : BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening. Genet Med 2012; 14: 688\u2013694.","journal-title":"Genet Med"},{"key":"BFejhg201669_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/1471-2407-12-320","volume":"12","author":"K Watts","year":"2012","unstructured":"Watts K, Meiser B, Mitchell G et al: How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer 2012; 12: 320.","journal-title":"BMC Cancer"},{"key":"BFejhg201669_CR19","volume-title":"Qualitative Data Analysis: A Methods Sourcebook","author":"MB Miles","year":"2014","unstructured":"Miles MB, Huberman AM, Saldana J : Qualitative Data Analysis: A Methods Sourcebook. 3rd edn. London: Sage, 2014."},{"key":"BFejhg201669_CR20","volume-title":"Qualitative Evaluation and Research Method","author":"M Patton","year":"2002","unstructured":"Patton M : Qualitative Evaluation and Research Method, 3rd edn London: Sage Publications, Inc., 2002."},{"key":"BFejhg201669_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/10906570260199320","volume":"6","author":"N Hallowell","year":"2002","unstructured":"Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M : Genetic testing for women previously diagnosed with breast\/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002; 6: 79\u201387.","journal-title":"Genet Test"},{"key":"BFejhg201669_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/109065704323015996","volume":"8","author":"E Claes","year":"2004","unstructured":"Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Leguis E : Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women looking back on the pre-test period and a psychological evaluation. Genet Test 2004; 8: 13\u201321.","journal-title":"Genet Test"},{"key":"BFejhg201669_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/109065704323015987","volume":"8","author":"S Loader","year":"2004","unstructured":"Loader S, Shields CG, Rowley PT : Impact of genetic testing for breast-ovarian cancer susceptibility. Genet Test 2004; 8: 1\u201312.","journal-title":"Genet Test"},{"key":"BFejhg201669_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10689-012-9596-5","volume":"12","author":"A Farrelly","year":"2013","unstructured":"Farrelly A, White V, Meiser B et al: Unmet support needs and distress among women with a BRCA1\/2 mutation. Fam Cancer 2013; 12: 509\u2013518.","journal-title":"Fam Cancer"},{"key":"BFejhg201669_CR25","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/jmg.37.11.866","volume":"37","author":"K Metcalfe","year":"2000","unstructured":"Metcalfe K, Liede A, Hoodfar E, Scott A, Foulkes W, Narod S : An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 2000; 37: 866\u2013874.","journal-title":"J Med Genet"},{"key":"BFejhg201669_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/07347330802359776","volume":"26","author":"A Werner-Lin","year":"2008","unstructured":"Werner-Lin A : Formal and informal support needs of young women with BRCA mutations. J Psychosoc Oncol 2008; 26: 111\u2013133.","journal-title":"J Psychosoc Oncol"},{"key":"BFejhg201669_CR27","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/cncr.20661","volume":"101","author":"MJ Esplen","year":"2004","unstructured":"Esplen MJ, Hunter J, Leszcz M et al: A multicenter study of supportive-expressive group therapy for women with BRCA1\/BRCA2 mutations. Cancer 2004; 101: 2327\u20132340.","journal-title":"Cancer"},{"key":"BFejhg201669_CR28","first-page":"423","volume":"21","author":"K Landsbergen","year":"2010","unstructured":"Landsbergen K, Brunner H, Manders P et al: Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress. Genet Couns 2010; 21: 423\u2013437.","journal-title":"Genet Couns"},{"key":"BFejhg201669_CR29","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.2013.54.1607","volume":"32","author":"V White","year":"2014","unstructured":"White V, Young M, Farrelly A et al: Randomized controlled trial of a Telephone-Based Peer-Support Program for women carrying a BRCA1 or BRCA2 mutation: impact on psychological distress. J Clin Oncol 2014; 32: 4073\u20134080.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201669","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:42Z","timestamp":1684430262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFejhg201669"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.69","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"type":"print","value":"1018-4813"},{"type":"electronic","value":"1476-5438"}],"subject":[],"published":{"date-parts":[[2016,6,22]]},"assertion":[{"value":"17 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}